ALK and non-small cell lung carcinoma: While individual serum from the nine ALK-positive NSCLC patients with high ALK autoantibody level detected different portions of the ALK cytoplasmic domain (Supplementary Figure 6), collectively the epitopes clustered mainly N-terminal and C-terminal to the ALK tyrosine kinase domain (Figure 3).